Many have taken these changes negatively, and while it all did happen at once, I am happy with it in the long run. The old CEO, Reynolds was overly exuberant in timelines. He did a GREAT job in my opinion gettin the company to where it is now ie FDA approval for HUD status, FDA approval for human trials, securing financing for a state of the art manufacturing and research facility in MA, but it was time to pass the baton to people with experience in getting this thing from R&D to revenue generating which could still take some time and while they have enough cash to last until the end of 2014-beginning of 2015 (they are also debt free) the people involved have acces to private equity sources.
Again, anything could happen, but I am comfortable with this companies path.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.